Skip to results
Modify your search
NARROW
1-10 of 10
Authors: Francesco Costa
Journal Article
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score
European Heart Journal, Volume 45, Issue 34, 7 September 2024, Pages 3138–3148, https://doi.org/10.1093/eurheartj/ehae463
Published: 17 July 2024
Journal Article
One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?
European Heart Journal, Volume 45, Issue 1, 1 January 2024, Pages 71–72, https://doi.org/10.1093/eurheartj/ehad729
Published: 20 November 2023
Journal Article
EDITOR'S CHOICE
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
European Heart Journal, Volume 44, Issue 11, 14 March 2023, Pages 954–968, https://doi.org/10.1093/eurheartj/ehac706
Published: 07 December 2022
Journal Article
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)
European Heart Journal, Volume 40, Issue 25, 1 July 2019, Pages 2070–2085, https://doi.org/10.1093/eurheartj/ehy377
Published: 09 July 2018
Journal Article
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
European Heart Journal, Volume 39, Issue 3, 14 January 2018, Pages e1–e33, https://doi.org/10.1093/eurheartj/ehx503
Published: 26 August 2017
Journal Article
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal, Volume 39, Issue 3, 14 January 2018, Pages 213–260, https://doi.org/10.1093/eurheartj/ehx419
Published: 26 August 2017
Journal Article
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial
European Heart Journal, Volume 38, Issue 11, 14 March 2017, Pages 804–810, https://doi.org/10.1093/eurheartj/ehw525
Published: 13 November 2016
Journal Article
FAST TRACK
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials Get access
European Heart Journal, Volume 37, Issue 4, 21 January 2016, Pages 390–399, https://doi.org/10.1093/eurheartj/ehv443
Published: 31 August 2015
Journal Article
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus? Get access
European Heart Journal, Volume 36, Issue 20, 21 May 2015, Pages 1219–1222, https://doi.org/10.1093/eurheartj/ehv053
Published: 11 March 2015
Journal Article
EDITOR'S CHOICE
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial Get access
European Heart Journal, Volume 36, Issue 20, 21 May 2015, Pages 1242–1251, https://doi.org/10.1093/eurheartj/ehv038
Published: 25 February 2015
